Revenue
257 million EUR
2023 · EUR
Exact inputs and evidence
- Revenue: 256675000 EUR Source
1 filing records in this dataset, filed from 2024-07-09 to 2024-07-09. Reported financial figures are available; chart coverage varies by period.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Insider reports are SEC Forms 3, 4 and 5. This company is not in the SEC regime, so none are shown.
Institutional holders (Form 13F) are not yet shown here.
155454000 EUR
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2024-07-09.
Financial data available through: 2023-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
EUR 129.2 million
–
Current period
EUR 256.68 million
–
256675000 − 129202000 = 127473000 EUR
129202000 EUR · 2022-01-01 – 2022-12-31
Inspect prior input Prior source256675000 EUR · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
EUR 33.05 million
–
Current period
EUR 15.98 million
–
15976000 − 33054000 = -17078000 EUR
33054000 EUR · 2022-01-01 – 2022-12-31
Inspect prior input Prior source15976000 EUR · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
EUR 995,000
–
Current period
EUR 34.19 million
–
34194000 − 995000 = 33199000 EUR
995000 EUR · 2022-01-01 – 2022-12-31
Inspect prior input Prior source34194000 EUR · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2022 2022-01-01 – 2022-12-31 | 129202000 | 118478000 Derived | 10724000 | -22330000 Derived | 33054000 | Unavailable | Source
|
| 2023 2023-01-01 – 2023-12-31 | 256675000 | 221686000 Derived | 34989000 | 19013000 Derived | 15976000 | Unavailable | Source
|
Amounts are exact, in EUR.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(EUR) | Source evidence |
|---|---|---|---|
| 2022 | Revenue | 129202000 |
|
| 2023 | Revenue | 256675000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | 98.7% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Operating margin | 8.3% |
|
| 2023 | Operating margin | 13.6% |
|
| 2022 | Net margin | 25.6% |
|
| 2023 | Net margin | 6.2% |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(EUR) | Source evidence |
|---|---|---|---|
| 2022 | Operating cash flow | 995000 |
|
| 2023 | Operating cash flow | 34194000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(EUR) | Source evidence |
|---|---|---|---|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Liabilities / assets | 48.9% |
|
| 2023 | Liabilities / assets | 81.5% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Current assets / current liabilities | 2.46× |
|
| 2023 | Current assets / current liabilities | 1.77× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2022 2022-01-01 – 2022-12-31 | EUR 33.05 million Exact valueExact value: 33054000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | EUR 995,000 Exact valueExact value: 995000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | EUR 15.98 million Exact valueExact value: 15976000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | EUR 34.19 million Exact valueExact value: 34194000 EUR Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
1 filings · 149 latest values · 149 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 2138005HALN2BC9VUD41, esef:2138005HALN2BC9VUD41